EP0401517A1 — Substituted 2-alkynylphenols with anti-inflammatory action, a process for their preparation and pharmaceutical compositions thereof
Assigned to Camillo Corvi SpA · Expires 1990-12-12 · 35y expired
What this patent protects
There are described new compounds of formula wherein R and R¹ are chosen independently from: hydrogen, hydroxyl, halogen, (C₁ - C₆) alkyl, (C₁ - C₄) alkoxy, benzyloxy, -COOR⁴; R² is : hydrogen, hydroxyl, (C₁ - C₆) alkyl, R-C₆H₄-; R³ is a methyl, R-aryl, heteroaryl, espec…
USPTO Abstract
There are described new compounds of formula wherein R and R¹ are chosen independently from: hydrogen, hydroxyl, halogen, (C₁ - C₆) alkyl, (C₁ - C₄) alkoxy, benzyloxy, -COOR⁴; R² is : hydrogen, hydroxyl, (C₁ - C₆) alkyl, R-C₆H₄-; R³ is a methyl, R-aryl, heteroaryl, especially furyl and thienyl, -COOR⁴ group; R⁴ is: hydrogen, (C₁ - C₆) alkyl; m is an integer of from 0 to 5; and a pharmaceutically acceptable salt thereof, methods for their preparation and their use as anti-inflammatory agents.
Drugs covered by this patent
- Oxbryta (voxelotor) · Global Blood Theraps
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.